CLINICAL_TRIALS
trial_result
· 2025-10-20
Clinical Trial Update: Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot) [Phase 2]
Summary
A Phase 2 pilot study (MAvERIC-Pilot) evaluating CardiolRx for recurrent pericarditis has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cardiol Therapeutics Inc. | Conditions: Recurrent Pericarditis | Phase 2 | Status: COMPLETED | Results posted: 2025-10-20